RE: 'Leap forward' in tailored cancer medicine11 Nov 2022 15:36
Don't worry, the rise is coming, and it will be considerable even just with HEMO CAR-T alone, but it's extremely likely to be next qtr. I too, share your frustrations, especially with the lack of communication. As I've said previously, I'm now not expecting much in the way of a rise for the rest of this year, and I'm cool with that. I've accepted it. We may get one more RNS this year, but I'm not counting on it either.
As for Vlad's tweets, just ignore them. If it's a tweet from Hemogenyx themselves, that's different.
Have a good weekend all :)